Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2018-12-10 Purchase | 2018-12-10 4:14 pm | Actinium Pharmaceuticals Inc. | ATNM | SETH SANDESH CEO Chairman | 10,000 | $0.4372 | $4,372 | 153,333 (Direct) | View |
| 2018-12-10 Purchase | 2018-12-10 4:10 pm | Actinium Pharmaceuticals Inc. | ATNM | O'Loughlin Steve Principal Financial Officer | 10,000 | $0.435 | $4,350 | 35,500 (Direct) | View |
| 2018-11-19 Purchase | 2018-11-20 5:08 pm | Actinium Pharmaceuticals Inc. | ATNM | Ludwig Dale L. Chief Scientific Officer | 10,000 | $0.4499 | $4,499 | 10,000 (Direct) | View |
| 2018-07-13 Purchase | 2018-07-17 5:13 pm | Actinium Pharmaceuticals Inc. | ATNM | SETH SANDESH CEO | 10,000 | $0.79 | $7,900 | 1,143,333 (Direct) | View |
| 2018-06-15 Purchase | 2018-06-15 6:08 pm | Actinium Pharmaceuticals Inc. | ATNM | O'Loughlin Steve Principal Financial Officer | 12,000 | $0.5 | $6,000 | 25,500 (Direct) | View |
| 2018-04-19 Purchase | 2018-04-20 4:15 pm | Actinium Pharmaceuticals Inc. | ATNM | SETH SANDESH CEO Chairman | 5,000 | $0.38 | $1,900 | 133,333 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2021-09-01 Option Award | 2021-09-03 5:05 pm | N/A 2031-09-01 | Actinium Pharmaceuticals Inc. | ATNM | Chell Jeffrey W. Director | 18,351 | $0 | 18,351 (Direct) | View |
| 2021-09-01 Option Award | 2021-09-03 5:04 pm | N/A 2031-09-01 | Actinium Pharmaceuticals Inc. | ATNM | Berger Mark Stanley Chief Medical Officer | 67,164 | $0 | 67,164 (Direct) | View |
| 2021-09-01 Option Award | 2021-09-03 5:03 pm | N/A 2031-09-01 | Actinium Pharmaceuticals Inc. | ATNM | Shetty Ajit Director | 18,351 | $0 | 18,351 (Direct) | View |
| 2021-09-01 Option Award | 2021-09-03 5:02 pm | N/A 2031-09-01 | Actinium Pharmaceuticals Inc. | ATNM | O'Loughlin Steve CFO | 107,463 | $0 | 107,463 (Direct) | View |
| 2021-09-01 Option Award | 2021-09-03 5:02 pm | N/A 2031-09-01 | Actinium Pharmaceuticals Inc. | ATNM | Steinhart Richard I Director | 18,351 | $0 | 18,351 (Direct) | View |
| 2021-09-01 Option Award | 2021-09-03 5:01 pm | N/A 2031-09-01 | Actinium Pharmaceuticals Inc. | ATNM | SETH SANDESH CEO | 310,182 | $0 | 310,182 (Direct) | View |
| 2021-09-01 Option Award | 2021-09-03 5:00 pm | N/A 2031-09-01 | Actinium Pharmaceuticals Inc. | ATNM | Nicholson C. David Director | 18,351 | $0 | 18,351 (Direct) | View |
| 2020-08-12 Option Award | 2020-08-14 5:21 pm | N/A 2030-08-12 | Actinium Pharmaceuticals Inc. | ATNM | O'Loughlin Steve CFO | 59,066 | $0 | 59,066 (Direct) | View |
| 2020-08-12 Option Award | 2020-08-14 5:21 pm | N/A 2030-08-12 | Actinium Pharmaceuticals Inc. | ATNM | SETH SANDESH CEO | 139,062 | $0 | 139,062 (Direct) | View |
| 2020-08-12 Option Award | 2020-08-14 5:18 pm | N/A 2030-08-12 | Actinium Pharmaceuticals Inc. | ATNM | Chell Jeffrey W. Director | 8,333 | $0 | 8,333 (Direct) | View |
| 2020-08-12 Option Award | 2020-08-14 5:17 pm | N/A 2030-08-12 | Actinium Pharmaceuticals Inc. | ATNM | Berger Mark Stanley Chief Medical Officer | 46,667 | $0 | 46,667 (Direct) | View |
| 2020-08-12 Option Award | 2020-08-14 5:03 pm | N/A 2030-08-12 | Actinium Pharmaceuticals Inc. | ATNM | Steinhart Richard I Director | 8,333 | $0 | 8,333 (Direct) | View |
| 2020-08-12 Option Award | 2020-08-14 5:03 pm | N/A 2030-08-12 | Actinium Pharmaceuticals Inc. | ATNM | Shetty Ajit Director | 8,333 | $0 | 8,333 (Direct) | View |
| 2020-08-12 Option Award | 2020-08-14 5:03 pm | N/A 2030-08-12 | Actinium Pharmaceuticals Inc. | ATNM | Ludwig Dale L. Chief Science & Tech. Officer | 50,000 | $0 | 50,000 (Direct) | View |
| 2020-08-12 Option Award | 2020-08-14 5:02 pm | N/A 2030-08-12 | Actinium Pharmaceuticals Inc. | ATNM | Nicholson C. David Director | 8,333 | $0 | 8,333 (Direct) | View |
| 2019-07-12 Option Award | 2019-07-16 5:19 pm | N/A 2029-07-12 | Actinium Pharmaceuticals Inc. | ATNM | Steinhart Richard I Director | 250,000 | $0.232 | 250,000 (Direct) | View |
| 2019-07-12 Option Award | 2019-07-16 5:16 pm | N/A 2029-07-12 | Actinium Pharmaceuticals Inc. | ATNM | Chell Jeffrey W. Director | 250,000 | $0.232 | 250,000 (Direct) | View |
| 2019-07-12 Option Award | 2019-07-16 5:13 pm | 2019-07-12 2029-07-12 | Actinium Pharmaceuticals Inc. | ATNM | Ludwig Dale L. Chief Scientific Officer | 400,000 | $0.232 | 400,000 (Direct) | View |
| 2019-07-12 Option Award | 2019-07-16 5:10 pm | 2019-07-12 2029-07-12 | Actinium Pharmaceuticals Inc. | ATNM | O'Loughlin Steve Principal Financial Officer | 400,000 | $0.232 | 400,000 (Direct) | View |
| 2019-07-12 Option Award | 2019-07-16 5:07 pm | 2019-07-12 2029-07-12 | Actinium Pharmaceuticals Inc. | ATNM | Berger Mark Stanley Chief Medical Officer | 400,000 | $0.232 | 400,000 (Direct) | View |
| 2019-07-12 Option Award | 2019-07-16 5:02 pm | 2019-07-12 2029-07-12 | Actinium Pharmaceuticals Inc. | ATNM | SETH SANDESH CEO | 1,500,000 | $0.232 | 1,500,000 (Direct) | View |
| 2019-07-12 Option Award | 2019-07-16 4:59 pm | 2019-07-12 2029-07-12 | Actinium Pharmaceuticals Inc. | ATNM | Kapur Anil Chief Commercial Officer | 400,000 | $0.232 | 400,000 (Direct) | View |
| 2019-07-12 Option Award | 2019-07-16 4:58 pm | N/A 2029-07-12 | Actinium Pharmaceuticals Inc. | ATNM | Shetty Ajit Director | 250,000 | $0.232 | 250,000 (Direct) | View |
| 2019-07-12 Option Award | 2019-07-16 4:55 pm | N/A 2029-07-12 | Actinium Pharmaceuticals Inc. | ATNM | Nicholson C. David Director | 250,000 | $0.232 | 250,000 (Direct) | View |
| 2019-03-05 Exercise | 2019-03-07 4:15 pm | N/A N/A | Actinium Pharmaceuticals Inc. | ATNM | Berger Mark Stanley Chief Medical Officer | 3,500 | $0.6 | 22,500 (Direct) | View |
| 2019-02-21 Exercise | 2019-02-21 4:45 pm | N/A N/A | Actinium Pharmaceuticals Inc. | ATNM | SETH SANDESH CEO Chairman | 8,125 | $0.6 | 161,458 (Direct) | View |
| 2018-07-13 Option Award | 2018-07-17 5:19 pm | N/A 2028-07-13 | Actinium Pharmaceuticals Inc. | ATNM | Nicholson C. David Director | 75,000 | $0.7829 | 75,000 (Direct) | View |
| 2018-07-13 Option Award | 2018-07-17 5:18 pm | N/A 2028-07-13 | Actinium Pharmaceuticals Inc. | ATNM | Chell Jeffrey W. Director | 75,000 | $0.7829 | 75,000 (Direct) | View |
| 2018-07-13 Option Award | 2018-07-17 5:17 pm | 2018-07-13 2028-07-13 | Actinium Pharmaceuticals Inc. | ATNM | Ray Nitya G. VP | 75,000 | $0.7829 | 75,000 (Direct) | View |
| 2018-07-13 Option Award | 2018-07-17 5:15 pm | 2018-07-13 2028-07-13 | Actinium Pharmaceuticals Inc. | ATNM | Berger Mark Stanley Chief Medical Officer | 250,000 | $0.7829 | 250,000 (Direct) | View |
| 2018-07-13 Option Award | 2018-07-17 5:13 pm | 2018-07-13 2028-07-13 | Actinium Pharmaceuticals Inc. | ATNM | SETH SANDESH CEO | 1,000,000 | $0.7829 | 1,143,333 (Direct) | View |
| 2018-07-13 Option Award | 2018-07-17 5:11 pm | 2018-07-13 2028-07-13 | Actinium Pharmaceuticals Inc. | ATNM | O'Loughlin Steve Principal Financial Officer | 265,000 | $0.7829 | 265,000 (Direct) | View |
| 2018-07-13 Option Award | 2018-07-17 5:10 pm | N/A 2028-07-13 | Actinium Pharmaceuticals Inc. | ATNM | Shetty Ajit Director | 75,000 | $0.7829 | 75,000 (Direct) | View |
| 2018-07-13 Option Award | 2018-07-17 5:04 pm | N/A 2028-07-13 | Actinium Pharmaceuticals Inc. | ATNM | Steinhart Richard I Director | 75,000 | $0.7829 | 75,000 (Direct) | View |
| 2018-04-27 Ownership | 2018-05-01 09:10 am | 2018-04-27 2028-04-27 | Actinium Pharmaceuticals Inc. | ATNM | Chell Jeffrey W. Director | 0 | $0 | 75,000 (Direct) | View |